This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Anacor Pharmaceuticals Inc (ANAC)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 114.76M 10.34M 15.17M 21.74M
Receivables 1.32M 1.20M 1.14M 1.19M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 155.41M 49.29M 53.04M 81.32M
Property, Plant & Equipment, Gross 6.72M 6.27M 5.83M 5.28M
Accumulated Depreciation & Depletion 5.26M 4.76M 4.09M 3.44M
Property, Plant & Equipment, Net 1.46M 1.52M 1.74M 1.84M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 15.29M 262.00K 1.00M 800.00K
Total Non-Current Assets 16.75M 1.78M 2.74M 2.64M
Liabilities & Shareholder Equity
Total Assets 172.16M 51.07M 55.79M 83.96M
Accounts Payable 4.71M 3.02M 3.02M 2.14M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 1.98M 0.00 0.00 0.00
Total Current Liabilities 16.23M 25.39M 21.02M 14.63M
Long Term Debt 28.02M 15.84M 13.71M 6.22M
Deferred Income Taxes 1.22M 836.00K 925.00K 902.00K
Other Non-Current Liabilities 5.27M 4.19M 6.23M 5.82M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 34.50M 20.87M 20.86M 12.94M
Total Liabilities 50.73M 46.26M 41.89M 27.57M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 121.43M 4.81M 13.90M 56.39M
Common Par 41.00K 36.00K 28.00K 28.00K
Additional Paid In Capital 251.84M 219.98M 173.00M 167.56M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -130.45M -215.21M -159.12M -111.18M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -2.00K 3.00K 0.00 -14.00K
Total Capitalization 149.45M 20.65M 27.60M 62.61M
Total Equity 121.43M 4.81M 13.90M 56.39M
Total Liabilities & Stock Equity 172.16M 51.07M 55.79M 83.96M
Total Common Shares Outstanding 41.54M 35.59M 28.19M 28.00M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 39.18M 31.90M 28.11M 18.53M
Diluted Weighted Shares Outstanding 40.32M 31.90M 28.11M 18.53M
Number of Employees 79 85 80 65
Number of Part-Time Employees 0 0 0 0
ANAC News

ANAC Anacor Pharmaceuticals Inc

Analysts Ratings for ANAC

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ANAC ANALYST REPORT

Brokerage Partners

ANAC Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs